Related Experiment Video
Updated: Jan 17, 2026

An Emerging Target Paradigm to Evoke Fast Visuomotor Responses on Human Upper Limb Muscles
Published on: August 25, 2020
Application of the target trial emulation framework to external comparator studies.
Kellyn Arnold1, Luis Antunes2, Briana Coles1
1IQVIA, Methods and Evidence Generation, London, United Kingdom.
External comparator studies are vital for evaluating new treatments, but their reliability varies. Applying the target trial emulation framework enhances the design and analysis of these real-world evidence studies for better reliability.
Area of Science:
- Health economics and outcomes research
- Pharmacoepidemiology
- Causal inference
Background:
- External comparator (EC) studies are crucial for evaluating emerging pharmacological treatments for regulatory and health technology assessment (HTA).
- The reliability of evidence from EC studies can be inconsistent, posing challenges for decision-making.
Purpose of the Study:
- To outline the application of the target trial emulation (TTE) framework to improve the design and analysis of EC studies.
- To enhance the clarity, transparency, and reliability of evidence generated from EC studies.
Main Methods:
- The study describes how to apply the existing TTE framework, a causal inference method, to EC studies.
- This involves specifying an ideal target trial protocol and emulating its key elements in real-world (RW) settings.
- Practical recommendations and special considerations for applying TTE to EC studies are provided.
Main Results:
- The TTE framework offers a structured approach to designing and analyzing EC studies.
- Application of TTE can lead to more robust and reliable real-world evidence.
- The paper details the adaptation of TTE components for EC study contexts.
Conclusions:
- The target trial emulation framework can significantly improve the quality of evidence from external comparator studies.
- Implementing TTE enhances the transparency and reliability of real-world evidence for treatment evaluations.
- This approach supports better regulatory and HTA decision-making regarding new pharmacological treatments.
More Related Videos
08:48Combining Multiple Data Acquisition Systems to Study Corticospinal Output and Multi-segment Biomechanics
Published on: January 9, 2016
07:25In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
Published on: May 4, 2017